Legislative/Policy/Regulatory Information
DEA Waiver Notification Form
Public Law 109-56
http://thomas.loc.gov/bss/d109/d109laws.html
Legislative History of Public Law 109-56
http://thomas.loc.gov/cgi-bin/query/r?r109:@OR+(+@1(S.+45)++)
S.45 Bill to amend the Controlled Substances Act to lift the patient
limitation on prescribing drug addiction treatments by medical
practitioners in group practices, and for other purposes.
http://thomas.loc.gov/cgi-bin/bdquery/z?d109:s.00045:
American Medical Association - Buprenorphine Policies
"Our AMA supports efforts to lift regulatory restrictions upon the number of opioid dependent patients any one certified physician may treat with buprenorphine. (Res. 541, A-06)"
http://www.ama-assn.org/apps/pf_new/pf_online?f_n=browse&doc=policyfiles/HnE/H-120.946.HTM
"Our AMA will support legislation and urge the Secretary of the Department of Health and Human Services to exercise administrative discretion to modify or eliminate the exclusion of various prescription drugs from coverage under Medicare Part D and ensure that CMS Medicare contractors that will administer the new Medicare Part D drug benefit, known as "prescription drug plans," include on their formularies for all clinically appropriate conditions including psychiatric and substance use disorder conditions, benzodiazepines, methadone, buprenorphine, acamprosate, disulfiram, and naltrexone, so that patients will have access to these critical medications. (Res. 717, I-05; Reaffirmation A-06)"
http://www.ama-assn.org/apps/pf_new/pf_online?f_n=browse&doc=policyfiles/DIR/D-330.942.HTM&&s_t=&st_p=&nth=1&prev_pol=policyfiles/DIR/D-320.999.HTM&nxt_pol=policyfiles/DIR/D-330.928.HTM&
"Our AMA will support and develop model legislation in the jurisdiction where it is most feasible to institute voluntary (for inmates) opioid replacement treatment pilot programs, (including methadone and buprenorphine maintenance treatment) in jails and prisons and these programs will be accompanied by an evaluation process to determine whether such treatment modalities decrease recidivism, crime, and transmission of infectious diseases among populations at risk in incarcerated settings in the states being studied. (Res. 443, A-05)"
http://www.ama-assn.org/apps/pf_new/pf_online?f_n=browse&doc=policyfiles/DIR/D-430.996.HTM&&s_t=&st_p=&nth=1&prev_pol=policyfiles/DIR/D-425.999.HTM&nxt_pol=policyfiles/DIR/D-430.996.HTM&&
|
